Using lipids derived from grapefruits, researchers at the University of Louisville have created nanoparticles for drug delivery that are less toxic to both people and the environment and may offer a less expensive alternative to synthetic materials.
Researchers at the University of Missouri have developed radioactive nanoparticles with the ability to target lymphoma tumor cells and shrink tumors after they have metastasized.
Industry observers are convinced that nanotechnology is set to become an important medium in the field of drug delivery. And the prospects for nanotech keep getting sweeter as innovations keep making headlines across a broad medical range. Read the report >>
A new nanoparticle drug-delivery platform created by researchers at Queen's University Belfast may be able to target and effectively treat severe lung trauma in patients in intensive care.
Researchers at the Frederick National Laboratory for Cancer Research have developed a way to enhance delivery of a cancer drug using nanoparticles, enabling more of the toxic therapy to reach the tumor without killing healthy cells.
With an increasing reliance on nanoparticles to deliver intravenous drug treatments and serve as imaging agents, how do you make sure they are powerful enough to reach their target? The answer: math.
Using a soccer-ball-shaped nanoparticle named after famed inventor Buckminster Fuller, researchers at Columbia Engineering have created a drug-delivery capsule with precise targeting capabilities.
Researchers from several U.S. institutions have created a 'smart' nanoparticle for insulin delivery that reacts to changes in blood chemistry and releases the protein when needed.
Pharmaco-Kinesis Corporation has combined two tested, on-the-market cancer drugs to form one super-drug. If successful, it will be the first combination nano-drug product candidate.
Researchers at Northeastern University have developed a treatment for Parkinson's disease meant to revive dying neurons in the brain via delivery through the nose.